EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer



RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer



Plos One 8(12): E84735-E84735



RBP2 has been found to actively participate in cancer progression. It inhibits the senescence of cancer cells, mediates cancer cell proliferation and promotes cancer metastasis. It is also essential to drug tolerance. However, the effects of RBP2 on epithelial-mesenchymal transition are still unknown. In this study, we analyzed the effects of RBP2 on epithelial-mesenchymal transition in non-small cell lung cancer. The results showed that RBP2 down-regulated the expression of E-cadherin by inhibiting the promoter activity of E-cadherin and up-regulated the expression of N-cadherin and snail via the activation of Akt signaling, and the overexpression of RBP2 induced epithelial-mesenchymal transition in non-small cell lung cancer cells. Our study further indicated that RBP2 may be a potential target for anti-lung cancer therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333676

Download citation: RISBibTeXText

PMID: 24376841

DOI: 10.1371/journal.pone.0084735



Related references

CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer. Oncology Reports 37(5): 3068-3074, 2017

CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells. Plos One 13(7): E0198823-E0198823, 2018

EML4-ALK induces epithelial-mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells. Biochemical and Biophysical Research Communications 459(3): 398-404, 2015

TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells. Experimental Cell Research, 2018

Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin. Molecular Cancer Therapeutics 11(11): 2362-2372, 2013

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. International Journal of Oncology 45(4): 1430-1436, 2015

Cinnamaldehyde induces apoptosis and reverses epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in non-small cell lung cancer. International Journal of Biochemistry & Cell Biology 84: 58-74, 2017

Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer. Oncotarget 8(38): 63691-63702, 2017

Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research 14(22): 7430-7437, 2008

The mechanisms for lung cancer risk of PM 2.5 : Induction of epithelial-mesenchymal transition and cancer stem cell properties in human non-small cell lung cancer cells. Environmental Toxicology 32(11): 2341-2351, 2017

Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer. Anticancer Research 37(4): 1773-1778, 2017

Epithelial-mesenchymal transition in non-small cell lung cancer. Der Pathologe 33 Suppl 2: 311-317, 2013

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma. Oncotarget 6(30): 29991-30005, 2016

Effect of AXL on the epithelial-to-mesenchymal transition in non-small cell lung cancer. Experimental and Therapeutic Medicine 14(1): 785-790, 2017

TASK-1 induces gefitinib resistance by promoting cancer initiating cell formation and epithelial-mesenchymal transition in lung cancer. Experimental and Therapeutic Medicine 15(1): 365-370, 2018